Xiangyu Qin

932 total citations
27 papers, 791 citations indexed

About

Xiangyu Qin is a scholar working on Cell Biology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Xiangyu Qin has authored 27 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cell Biology, 12 papers in Molecular Biology and 11 papers in Organic Chemistry. Recurrent topics in Xiangyu Qin's work include Aldose Reductase and Taurine (12 papers), Synthesis and Biological Evaluation (5 papers) and Heme Oxygenase-1 and Carbon Monoxide (4 papers). Xiangyu Qin is often cited by papers focused on Aldose Reductase and Taurine (12 papers), Synthesis and Biological Evaluation (5 papers) and Heme Oxygenase-1 and Carbon Monoxide (4 papers). Xiangyu Qin collaborates with scholars based in China, United States and United Kingdom. Xiangyu Qin's co-authors include Changjin Zhu, Bing Ma, Yanchun Yang, Xin Hao, Saghir Hussain, Chaojun Jing, Shagufta Parveen, Xin Chen, Hui Han and Shuzhen Zhang and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Frontiers in Immunology.

In The Last Decade

Xiangyu Qin

27 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangyu Qin China 12 452 153 146 83 66 27 791
Monika Dąbrowska Poland 15 89 0.2× 220 1.4× 104 0.7× 21 0.3× 37 0.6× 71 645
Xiong Li China 18 171 0.4× 138 0.9× 22 0.2× 23 0.3× 167 2.5× 33 718
Christine Gottardo Canada 14 320 0.7× 126 0.8× 25 0.2× 24 0.3× 106 1.6× 25 664
Miloš Petković Serbia 14 226 0.5× 160 1.0× 33 0.2× 13 0.2× 36 0.5× 58 582
Kênnia Rocha Rezende Brazil 12 45 0.1× 104 0.7× 22 0.2× 53 0.6× 62 0.9× 34 414
Tzenge‐Lien Shih Taiwan 15 307 0.7× 175 1.1× 16 0.1× 23 0.3× 41 0.6× 58 578
Xie Wang China 17 440 1.0× 149 1.0× 15 0.1× 20 0.2× 54 0.8× 52 762
Paulina Mucha Poland 12 152 0.3× 66 0.4× 20 0.1× 55 0.7× 37 0.6× 23 442
И. В. Сорокина Russia 14 165 0.4× 227 1.5× 6 0.0× 67 0.8× 43 0.7× 53 591
Romain Reynaud France 15 28 0.1× 282 1.8× 84 0.6× 70 0.8× 89 1.3× 45 673

Countries citing papers authored by Xiangyu Qin

Since Specialization
Citations

This map shows the geographic impact of Xiangyu Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyu Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyu Qin more than expected).

Fields of papers citing papers by Xiangyu Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyu Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyu Qin. The network helps show where Xiangyu Qin may publish in the future.

Co-authorship network of co-authors of Xiangyu Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyu Qin. A scholar is included among the top collaborators of Xiangyu Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyu Qin. Xiangyu Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qixuan, et al.. (2025). The role of immunity in insulin resistance in patients with polycystic ovary syndrome. Frontiers in Endocrinology. 15. 1464561–1464561. 1 indexed citations
2.
Qin, Xiangyu, et al.. (2024). RNA modifications in cancer immune therapy: regulators of immune cells and immune checkpoints. Frontiers in Immunology. 15. 1463847–1463847. 3 indexed citations
3.
Qin, Xiangyu, Zhiyu Wu, Yanran Li, et al.. (2023). BERT-ERC: Fine-Tuning BERT Is Enough for Emotion Recognition in Conversation. Proceedings of the AAAI Conference on Artificial Intelligence. 37(11). 13492–13500. 20 indexed citations
4.
Qin, Xiangyu, Yuan‐Hang Chang, Yao Wang, et al.. (2023). Aspergillus sp. R3, a new producer for cyclopyazonic acid, inhibits rice sheath blight fungus Rhizoctonia solani Kühn. Physiological and Molecular Plant Pathology. 125. 102007–102007. 6 indexed citations
5.
Wang, Yao, Xu Han, Xiangyu Qin, et al.. (2023). A solid preparation of phytochemicals: improvement of the solubility and bioavailability of astragaloside IV based on β-cyclodextrin microencapsulation. Chemical Papers. 77(11). 6491–6503. 4 indexed citations
6.
Qin, Xiangyu, et al.. (2023). CircularRNA Hsa_circ_0093335 promotes hepatocellular carcinoma progression via sponging miR‐338‐5p. Journal of Cellular and Molecular Medicine. 27(24). 4080–4092. 2 indexed citations
8.
Niu, Lili, Xiangyu Qin, Litao Wang, et al.. (2022). Upgrading the accumulation of ginsenoside Rd in Panax notoginseng by a novel glycosidase-producing endophytic fungus G11-7. Folia Microbiologica. 68(3). 441–452. 1 indexed citations
9.
Yang, Jie, Ruijin Ma, Yuan‐Hang Chang, et al.. (2022). Genome-wide transcriptome analysis and characterization of the cytochrome P450 flavonoid biosynthesis genes in pigeon pea (Cajanus cajan). Planta. 255(6). 120–120. 15 indexed citations
10.
Zhao, Xuelian, Liang Yu, Sun-Dong Zhang, et al.. (2020). Cryptochlorogenic acid attenuates LPS-induced inflammatory response and oxidative stress via upregulation of the Nrf2/HO-1 signaling pathway in RAW 264.7 macrophages. International Immunopharmacology. 83. 106436–106436. 74 indexed citations
11.
Qin, Xiangyu, et al.. (2019). Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries. Current Radiopharmaceuticals. 12(3). 187–200. 5 indexed citations
12.
Hao, Xin, et al.. (2016). Synthesis of benzothiadiazine derivatives exhibiting dual activity as aldose reductase inhibitors and antioxidant agents. Bioorganic & Medicinal Chemistry Letters. 26(12). 2880–2885. 6 indexed citations
13.
Qin, Xiangyu, Xin Hao, Wei Zhang, et al.. (2015). Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1H)-one as potent aldose reductase inhibitors with antioxidant activity. Bioorganic & Medicinal Chemistry Letters. 25(18). 3924–3927. 30 indexed citations
15.
Parveen, Shagufta, Saghir Hussain, Xiangyu Qin, et al.. (2014). Selective synthesis and comparative activity of olefinic isomers of 1,2-benzothiazine-1,1-dioxide carboxylates as aldose reductase inhibitors. RSC Advances. 4(40). 21134–21134. 9 indexed citations
16.
Hussain, Saghir, Shagufta Parveen, Xin Hao, et al.. (2014). Structure–activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors. European Journal of Medicinal Chemistry. 80. 383–392. 116 indexed citations
17.
Hao, Xin, Xiangyu Qin, Saghir Hussain, et al.. (2014). Chiral resolution, determination of absolute configuration, and biological evaluation of (1,2-benzothiazin-4-yl)acetic acid enantiomers as aldose reductase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 30(5). 846–851. 7 indexed citations
18.
Hussain, Saghir, Shagufta Parveen, Xiangyu Qin, et al.. (2014). Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(9). 2086–2089. 16 indexed citations
19.
Yang, Yanchun, Xiangyu Qin, Shuzhen Zhang, et al.. (2013). Synthesis and Structure–Activity Relationship Studies of Quinoxaline Derivatives as Aldose Reductase Inhibitors. ChemMedChem. 8(12). 1913–1917. 72 indexed citations
20.
Yang, Yanchun, Shuzhen Zhang, Mingming Ma, et al.. (2012). An Efficient Synthesis of Quinoxalinone Derivatives as Potent Inhibitors of Aldose Reductase. ChemMedChem. 7(5). 823–835. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026